Synopsis of recent research by authors named "Claudia Manzo"
- Claudia Manzo's research primarily focuses on the impact and implementation of Risk Evaluation and Mitigation Strategies (REMS) in healthcare, particularly regarding medications with serious safety concerns, such as endothelium receptor antagonists used for pulmonary arterial hypertension.
- In her 2024 article, she analyzed the effects of removing the boxed hepatotoxicity warning and liver function testing requirements for ambrisentan, finding significant shifts in its usage and monitoring practices following changes in labeling.
- Her work aims to bridge gaps in understanding the effectiveness of REMS programs, highlighting the need for comprehensive evaluations that consider patient outcomes, medication access, and informed decision-making.